abstract |
A pharmaceutical composition comprising a chalcone compound exhibiting an inhibitory activity to matrix metalloproteinases (MMP) and a pharmaceutically acceptable diluent or carrier, in which the chachalcone compound exhibiting an inhibitory activity to matrix metalloproteinases (MMP) is selected from the group consisting of 4-methoxy-chalcone, 4'-methoxy-chalcone and 2 ', 4'-dimethoxy-chalcone. |